{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:08:27Z","timestamp":1764281307093,"version":"3.46.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.anndiagpath.2025.152569","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:49:40Z","timestamp":1759340980000},"page":"152569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inflammatory myofibroblastic tumors of the skin and mucosal sites: A clinicopathological and molecular analysis of 3 cases with emphasis on differential diagnosis"],"prefix":"10.1016","volume":"80","author":[{"given":"Danting","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152569_bb0005","series-title":"WHO classification of tumours editorial board. Soft tissue and bone tumours","first-page":"109","article-title":"Inflammatory myofibroblastic tumour","author":"Yamamoto","year":"2020"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","article-title":"Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases","volume":"19","author":"Coffin","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: where are we now?","volume":"61","author":"Gleason","year":"2008","journal-title":"J Clin Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152569_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.0303-6987.2004.00239.x","article-title":"Cutaneous inflammatory pseudotumor--a spectrum of various diseases?","volume":"31","author":"El Shabrawi-Caelen","year":"2004","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152569_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/his.12759","article-title":"Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases","volume":"68","author":"Leguellec","year":"2016","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152569_bb0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/cup.14261","article-title":"Cutaneous inflammatory myofibroblastic tumor with CARS-ALK fusion: case report and literature review","volume":"49","author":"McCollum","year":"2022","journal-title":"J Cutan Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152569_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/cup.14610","article-title":"Fusion-driven cutaneous and superficial mesenchymal and adnexal tumors-a clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2-rearranged adnexal carcinoma","volume":"51","author":"Dehner","year":"2024","journal-title":"J Cutan Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152569_bb0045","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/PAS.0000000000001735","article-title":"Clinicopathologic and genomic characterization of inflammatory myofibroblastic tumors of the head and neck: highlighting a novel fusion and potential diagnostic pitfall","volume":"45","author":"Kerr","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152569_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15513815.2017.1385667","article-title":"Inflammatory myofibroblastic tumor of the tongue. Report of a pediatric case and review of the literature","volume":"37","author":"Caporalini","year":"2018","journal-title":"Fetal Pediatr Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152569_bb0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1309\/AJCPCG8D6JAQBVLG","article-title":"Polypoid laryngeal inflammatory myofibroblastic tumors: misleading lesions: description of six cases showing ALK overexpression","volume":"144","author":"Pierry","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152569_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.path.2023.06.008","article-title":"Inflammatory rhabdomyoblastic tumor: from a nebulous smooth muscle neoplasm to a novel skeletal muscle tumor subtype","volume":"17","author":"Michal","year":"2024","journal-title":"Surg Pathol Clin"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152569_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.semdp.2025.150917","article-title":"Inflammatory rhabdomyoblastic tumor: a review and update","volume":"42","author":"Folpe","year":"2025","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152569_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.70035","article-title":"PDGFRA::USP8 fusion in a cutaneous inflammatory myofibroblastic tumor, highlighting genetic pleiotropy of kinase gene fusions in soft tissue neoplasms","volume":"64","author":"Vernemmen","year":"2025","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152569_bb0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/DAD.0000000000002096","article-title":"Primary cutaneous epithelioid inflammatory myofibroblastic sarcoma harboring RANBP2-ALK fusion: report of an exceptional case","volume":"44","author":"Gadeyne","year":"2022","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2025.152569_bb0090","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/PAS.0000000000002283","article-title":"ALK -rearranged mesenchymal neoplasms with prominent foamy\/pseudolipogenic cell morphology\u202f: expanding the phenotypic spectrum of ALK fusion neoplasms and report of novel fusion partners","volume":"48","author":"Agaimy","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152569_bb0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41379-018-0145-0","article-title":"Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms","volume":"32","author":"Martinez","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152569_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100359","article-title":"Inflammatory rhabdomyoblastic tumor: clinicopathologic and molecular analysis of 13 cases","volume":"37","author":"Odate","year":"2024","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152569_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/his.14323","article-title":"Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases","volume":"79","author":"Xu","year":"2021","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152569_bb0110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00428-024-04007-z","article-title":"Primary cutaneous rhabdomyosarcoma with EWSR1\/FUS::TFCP2 fusion: four new cases with distinctive morphology, immunophenotypic, and genetic profile","volume":"486","author":"Machado","year":"2025","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152569_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132330","article-title":"Understanding the interplay between expression, mutation and activity of ALK receptor in rhabdomyosarcoma cells for clinical application of small-molecule inhibitors","volume":"10","author":"Peron","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152569_bb0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2011.37.8588","article-title":"Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications","volume":"30","author":"van Gaal","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152569_bb0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41467-023-44360-2","article-title":"Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions","volume":"15","author":"Sch\u00f6pf","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152569_bb0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/his.14449","article-title":"Evolving classification of rhabdomyosarcoma","volume":"80","author":"Agaram","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2023.12.004","article-title":"Rhabdomyosarcoma: updates on classification and the necessity of molecular testing beyond immunohistochemistry","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.pas.0000157294.55796.d3","article-title":"Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases","volume":"29","author":"Lazar","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152569_bb0150","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/PAS.0000000000001122","article-title":"Cutaneous non-neural granular cell tumors harbor recurrent ALK gene fusions","volume":"42","author":"Cohen","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0155","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/his.13645","article-title":"A subset of so-called dermal non-neural granular cell tumours are underlined by ALK fusions, further supporting the idea that they represent a variant of epithelioid fibrous histiocytoma","volume":"73","author":"Perret","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2559.1994.tb01290.x","article-title":"Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant","volume":"24","author":"Gomez","year":"1994","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152569_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2017.191","article-title":"Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases","volume":"31","author":"Dickson","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152569_bb0170","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-0560.2011.01747.x","article-title":"EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall","volume":"38","author":"Doyle","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0175","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41379-021-00830-w","article-title":"Superficial ALK rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile","volume":"34","author":"Dermawan","year":"2021","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152569_bb0180","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/PAS.0000000000002315","article-title":"Epithelioid fibrous histiocytoma is on a continuum with superficial ALK-rearranged myxoid spindle cell neoplasm\u202f: a clinicopathologic series of 35 cases including alternate RET and NTRK3 fusions","volume":"48","author":"DeSimone","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0185","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/cup.13923","article-title":"Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: cases series and review of the literature","volume":"48","author":"Kazlouskaya","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152569_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cup.14732","article-title":"Multisystem ALK-positive histiocytosis with DCTN1::ALK fusion in an adult, responsive to Alectinib: case report and literature review","volume":"52","author":"Phillips","year":"2025","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152569_bb0195","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-022-03389-2","article-title":"TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: a report of 7 cases","volume":"481","author":"Klub\u00ed\u010dkov\u00e1","year":"2022","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152569_bb0200","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2020.09.005","article-title":"Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases","volume":"106","author":"Makhdoum","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152569_bb0210","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21(24):9739","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:04:56Z","timestamp":1764281096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"alternative-id":["S1092913425001340"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152569","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory myofibroblastic tumors of the skin and mucosal sites: A clinicopathological and molecular analysis of 3 cases with emphasis on differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152569"}}